{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:02:23Z","timestamp":1791234143818,"version":"4.1.0"},"reference-count":36,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","award":["GINOP-2.3.2-15-2016-00050"],"award-info":[{"award-number":["GINOP-2.3.2-15-2016-00050"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","award":["GINOP-2.3.2-15-2016-00015"],"award-info":[{"award-number":["GINOP-2.3.2-15-2016-00015"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Debrecen Program for Scientific Publication"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Multiple myeloma (MM) remains an incurable plasma cell malignancy with heterogeneous clinical outcomes. Although current prognostic systems integrate biochemical and cytogenetic parameters, they do not fully capture disease complexity. Adipocytes within the bone marrow microenvironment secrete adipokines that regulate inflammation, metabolism, and immune interactions and may influence disease progression. This study aimed to assess circulating adipokines and related microenvironmental mediators as potential biomarkers of disease activity and treatment response in MM. Materials and Methods: In this case\u2013control, cross-sectional study, the serum levels of eight adipokine-related molecules\u2014adiponectin, leptin, resistin, chemerin, adipsin, thrombospondin-1 (TSP-1), paraoxonase-1 (PON-1), and myeloperoxidase (MPO)\u2014were measured in 40 MM patients and 38 age- and sex-matched healthy controls. Enzyme-linked immunosorbent assays (ELISA) and bead-based multiplex immunoassays were used. Associations with prognostic markers (serum \u03b22-microglobulin (sB2M), LDH, albumin, hemoglobin, renal function) and treatment response were analyzed using correlation and non-parametric statistical methods. Results: Compared to the controls, MM patients exhibited significantly higher circulating levels of adiponectin, resistin, chemerin, adipsin, TSP-1, and MPO, while leptin was decreased. Among clinical correlations, chemerin and PON-1 correlated positively with sB2M, TSP-1 correlated with LDH, and MPO correlated with M-protein and albumin. Resistin was lower in patients with renal impairment and an advanced disease stage. Adiponectin and TSP-1 were significantly lower in progressive disease compared to complete remission, suggesting their potential association with treatment response. Conclusions: This study demonstrates that multiple adipokines are dysregulated in MM and exhibit distinct associations with disease burden, renal function, and therapeutic response. Novel associations identified for TSP-1, PON-1, and adipsin highlight previously unrecognized microenvironmental pathways in MM biology. Adipokine profiling may complement established prognostic markers and provide new insights into the tumour microenvironment in MM.<\/jats:p>","DOI":"10.3390\/medicina61112065","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:44:53Z","timestamp":1763631893000},"page":"2065","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Adipokines as Prognostic Biomarkers in Multiple Myeloma: A Case\u2013Control Study"],"prefix":"10.3390","volume":"61","author":[{"given":"N\u00f3ra","family":"Obajed Al-Ali","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary"},{"name":"Doctoral School of Clinical Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5082-3944","authenticated-orcid":false,"given":"D\u00f3ra","family":"Csige","sequence":"additional","affiliation":[{"name":"Doctoral School of Clinical Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary"},{"name":"Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0453-1709","authenticated-orcid":false,"given":"L\u00e1szl\u00f3 Imre","family":"Pincz\u00e9s","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary"},{"name":"Doctoral School of Clinical Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Farkas","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary"},{"name":"Doctoral School of Clinical Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4959-7587","authenticated-orcid":false,"given":"Istv\u00e1n","family":"Rebenku","sequence":"additional","affiliation":[{"name":"Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Domj\u00e1n","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6227-3301","authenticated-orcid":false,"given":"Gy\u00f6rgy","family":"Panyi","sequence":"additional","affiliation":[{"name":"Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Szekanecz","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0958-9531","authenticated-orcid":false,"given":"Gabriella","family":"Sz\u0171cs","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1rp\u00e1d","family":"Ill\u00e9s","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary"},{"name":"Doctoral School of Clinical Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"V\u00e1r\u00f3czy","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary"},{"name":"Doctoral School of Clinical Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/ajh.27422","article-title":"Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management","volume":"99","author":"Rajkumar","year":"2024","journal-title":"Am. J. Hematol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group","volume":"33","author":"Palumbo","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1182\/bloodadvances.2023010843","article-title":"Mass spectrometry-detected MGUS is associated with obesity and other novel modifiable risk factors in a high-risk population","volume":"8","author":"Lee","year":"2024","journal-title":"Blood Adv."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1611338","DOI":"10.3389\/pore.2023.1611338","article-title":"Obesity as a risk factor for multiple myeloma: Insight on the role of adipokines","volume":"29","author":"Tie","year":"2023","journal-title":"Pathol. Oncol. Res."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Ding, Y., Zhang, Y., Zhang, X., Shang, M., and Dong, F. (2024). Association of lipid levels, adipokines and multiple myeloma: A two-sample multivariate Mendelian randomization study. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-74838-y"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Falank, C., Fairfield, H.H., and Reagan, M.R. (2016). Signaling interplay between Bone Marrow Adipose Tissue and Multiple Myeloma cells. Front. Endocrinol., 7.","DOI":"10.3389\/fendo.2016.00067"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.33549\/physiolres.930848","article-title":"Adipocytokines and cancer","volume":"55","author":"Housa","year":"2006","journal-title":"Physiol. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1007\/s00018-019-03031-6","article-title":"Role of bone marrow adipocytes in leukemia and chemotherapy challenges","volume":"76","author":"Samimi","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"9159","DOI":"10.1002\/jcp.26884","article-title":"Adipokines, adiposity, and bone marrow adipocytes: Dangerous accomplices in multiple myeloma","volume":"233","author":"Morris","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s13679-025-00644-w","article-title":"Unraveling Obesity and Multiple Myeloma: Insights from Epidemiology and Molecular Mechanisms","volume":"14","author":"Manna","year":"2025","journal-title":"Curr. Obes. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.1182\/blood-2012-06-438606","article-title":"A prospective study of circulating adipokine levels and risk of multiple myeloma","volume":"120","author":"Hofmann","year":"2012","journal-title":"Blood"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/oby.21894","article-title":"Circulating Adiponectin Levels Differ Between Patients with Multiple Myeloma and its Precursor Disease","volume":"25","author":"Hofmann","year":"2017","journal-title":"Obesity"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1158\/0008-5472.CAN-15-2406","article-title":"Low Levels of Circulating Adiponectin Are Associated with Multiple Myeloma Risk in Overweight and Obese Individuals","volume":"76","author":"Hofmann","year":"2016","journal-title":"Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1532\/IJH97.NA0411","article-title":"Association of plasma adiponectin concentrations with chronic lymphocytic leukemia and myeloproliferative diseases","volume":"83","author":"Avcu","year":"2006","journal-title":"Int. J. Hematol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1210\/jc.2010-0086","article-title":"Plasma adiponectin levels are markedly elevated in imatinib-treated chronic myeloid leukemia (CML) patients: A mechanism for improved insulin sensitivity in type 2 diabetic CML patients?","volume":"95","author":"Fitter","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"86075","DOI":"10.18632\/oncotarget.13342","article-title":"Adipocytes secreted leptin is a pro-tumor factor for survival of multiple myeloma under chemotherapy","volume":"7","author":"Yu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/172460080401900107","article-title":"Serum Levels of Leptin in Multiple Myeloma Patients and Its Relation to Angiogenic and Inflammatory Cytokines","volume":"19","author":"Alexandrakis","year":"2004","journal-title":"Int. J. Biol. Markers"},{"key":"ref_19","first-page":"1112","article-title":"Adiponectin inhibits the differentiation and maturation of osteoclasts via the mTOR pathway in multiple myeloma","volume":"45","author":"Liu","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/bjc.2017.282","article-title":"Circulating resistin levels and risk of multiple myeloma in three prospective cohorts","volume":"117","author":"Santo","year":"2017","journal-title":"Br. J. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/jcb.20915","article-title":"Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism","volume":"99","author":"Thommesen","year":"2006","journal-title":"J. Cell. Biochem."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Liu, R., Gao, D., Lv, Y., Zhai, M., and He, A. (2022). Importance of circulating adipocytokines in multiple myeloma: A systematic review and meta-analysis based on case-control studies. BMC Endocr. Disord., 22.","DOI":"10.1186\/s12902-022-00939-2"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3324\/haematol.2016.154062","article-title":"Resistin induces multidrug resistance in myeloma by inhibiting cell death and upregulating ABC transporter expression","volume":"102","author":"Pang","year":"2017","journal-title":"Haematologica"},{"key":"ref_24","first-page":"1","article-title":"Chemerin regulation and role in host defense","volume":"3","author":"Zabel","year":"2014","journal-title":"Am. J. Clin. Exp. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Westhrin, M., Moen, S.H., Kristensen, I.B., Buene, G., Mylin, A.K., Turesson, I., Abildgaard, N., Waage, A., and Standal, T. (2018). Chemerin is elevated in multiple myeloma patients and is expressed by stromal cells and pre-adipocytes. Biomark. Res., 6.","DOI":"10.1186\/s40364-018-0134-y"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Behnoush, A.H., Shobeiri, P., Bahiraie, P., Amirkhani, N., Khalaji, A., and Peiman, S. (2023). Chemerin levels in chronic kidney disease: A systematic review and meta-analysis. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1120774"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0272-6386(89)80119-2","article-title":"\u03b2 2-Microglobulin Levels in Patients With Renal Insufficiency","volume":"13","author":"Acchiardo","year":"1989","journal-title":"Am. J. Kidney Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"34329","DOI":"10.18632\/oncotarget.6020","article-title":"Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Sun, S., Dong, H., Yan, T., Li, J., Liu, B., Shao, P., Li, J., and Liang, C. (2020). Role of TSP-1 as prognostic marker in various cancers: A systematic review and meta-analysis. BMC Med. Genet., 21.","DOI":"10.1186\/s12881-020-01073-3"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Wu, X., Guo, J., Deng, H., and Chen, W. (2025). Serum proteome profiling identified thrombospondin-1 and lactoferrin as biomarkers of relapsed multiple myeloma. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1640245"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bcp.2010.11.008","article-title":"Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: The hunt goes on","volume":"81","author":"Costa","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1189\/jlb.1204697","article-title":"Myeloperoxidase: Friend and foe","volume":"77","author":"Klebanoff","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.biocel.2015.09.006","article-title":"Uncovering a new role for peroxidase enzymes as drivers of angiogenesis","volume":"68","author":"Panagopoulos","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3892\/ijo.2017.3883","article-title":"Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment","volume":"50","author":"Panagopoulos","year":"2017","journal-title":"Int. J. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/ajcp\/aqx021","article-title":"Clinical Significance of Isolated Myeloperoxidase Expression in Pediatric B-Lymphoblastic Leukemia","volume":"147","author":"Oberley","year":"2017","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/bjh.19102","article-title":"Myeloperoxidase creates a permissive microenvironmental niche for the progression of multiple myeloma","volume":"203","author":"Williams","year":"2023","journal-title":"Br. J. Haematol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/11\/2065\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T10:44:08Z","timestamp":1763635448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/11\/2065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":36,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["medicina61112065"],"URL":"https:\/\/doi.org\/10.3390\/medicina61112065","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]}}}